Vitamin D Status Is Associated with Metabolic Syndrome in a Clinic-Based Sample of Hispanic Adults

Overview

Journal Metab Syndr Relat Disord

Date 2016 Jan 8

PMID 26741699

Citations 6

Authors

Giselle M Diaz

Lilliana Gonzalez

Grisel Ramos-Trautmann

Cynthia Marie Perez

Cristina Palacios

Affiliations

Soon will be listed here.

Abstract

Background: Vitamin D status has been associated with metabolic syndrome (MetSyn) and its components in different populations, but few studies have assessed this among Hispanics. The objective of this analysis was to assess such association in a clinic-based sample of Hispanic adults.

Methods: Medical records were reviewed retrospectively for the years 2005-2013. MetSyn was assessed using the revised NCEP-ATP III criteria. Vitamin D status was evaluated from reported serum 25(OH)D levels. A multivariable logistic regression model was used to assess the association between MetSyn risk and vitamin D status, controlling for important confounders.

Results: From 1379 medical records evaluated, 712 met the inclusion criteria. Most were females (62.6%), with a mean age of 53.8 ± 14.1 years, mean body mass index (BMI) of 30.1 ± 6.4 kg/m(2), and mean serum 25(OH)D levels of 24.4 ± 8.3 ng/mL. MetSyn was identified in 40.5% of the participants. Serum 25(OH)D levels in those with MetSyn (22.7 ± 8.0 ng/mL) were significantly lower compared to those without MetSyn (25.5 ± 8.4 ng/mL; P < 0.001). Serum 25(OH)D levels were inversely correlated to triglycerides, waist circumference, and fasting blood glucose (P < 0.05). In the multivariable logistic regression model, decreased serum 25(OH)D levels were associated with higher odds of MetSyn, even after adjusting for age, gender, BMI, and seasonality.

Conclusion: In this clinic-based sample, the odds of MetSyn increased as serum 25(OH)D levels decreased. These results have important public health implications for developing recommendations directed to increase vitamin D status in this sample.

Citing Articles

Vitamin D status and prevalence of metabolic syndrome by race and Hispanic origin in US adults: findings from the 2007-2014 NHANES.

Ahluwalia N, Raghavan R, Zhang G, Talegawkar S, Jacques P Am J Clin Nutr. 2022; 116(5):1400-1408.

PMID: 36036472 PMC: 10474946. DOI: 10.1093/ajcn/nqac234.

Insulin Resistance Is Inversely Associated with the Status of Vitamin D in Both Diabetic and Non-Diabetic Populations.

Rafiq S, Jeppesen P Nutrients. 2021; 13(6).

PMID: 34063822 PMC: 8224049. DOI: 10.3390/nu13061742.

Vitamin D Status and Correlation with Glucose and Lipid Metabolism in Gansu Province, China.

Yang K, Liu J, Fu S, Tang X, Ma L, Sun W Diabetes Metab Syndr Obes. 2020; 13:1555-1563.

PMID: 32440184 PMC: 7216298. DOI: 10.2147/DMSO.S249049.

Prevalence of Hearing Disorders among Type 2 Diabetes Mellitus Patients with and without Vitamin D Deficiency.

Hosseini M, Saeedi M, KHALKHALi S Maedica (Bucur). 2020; 15(1):32-36.

PMID: 32419858 PMC: 7221282. DOI: 10.26574/maedica.2020.15.1.32.

Predictors of 25-hydroxyvitamin D status among individuals with metabolic syndrome: a cross-sectional study.

Aquino S, da Cunha A, Pereira H, Silva Freitas E, Fayh A, Lima J Diabetol Metab Syndr. 2018; 10:45.

PMID: 29928318 PMC: 5987652. DOI: 10.1186/s13098-018-0346-1.

References

Liu S, Song Y, Ford E, Manson J, Buring J, Ridker P . Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005; 28(12):2926-32. DOI: 10.2337/diacare.28.12.2926. View

Eckel R, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2005; 365(9468):1415-28. DOI: 10.1016/S0140-6736(05)66378-7. View

Dugan C, Fernandez M . Effects of dairy on metabolic syndrome parameters: a review. Yale J Biol Med. 2014; 87(2):135-47. PMC: 4031787. View

Wong K, Szeto F, Zhang W, Ye H, Kong J, Zhang Z . Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab. 2009; 296(4):E820-8. PMC: 2670625. DOI: 10.1152/ajpendo.90763.2008. View

Boudreau D, Malone D, Raebel M, Fishman P, Nichols G, Feldstein A . Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord. 2009; 7(4):305-14. DOI: 10.1089/met.2008.0070. View

Palacios C, Gonzalez L . Is vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol. 2013; 144 Pt A:138-45. PMC: 4018438. DOI: 10.1016/j.jsbmb.2013.11.003. View

Beltran-Sanchez H, Harhay M, Harhay M, McElligott S . Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013; 62(8):697-703. PMC: 3756561. DOI: 10.1016/j.jacc.2013.05.064. View

Wortsman J, Matsuoka L, Chen T, Lu Z, Holick M . Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72(3):690-3. DOI: 10.1093/ajcn/72.3.690. View

Suarez-Martinez E, Perez C, Cruz S, Khorsandi S, Chardon C, Ferder L . Importance of vitamin D and vitamin D levels status in Puerto Ricans. J Health Care Poor Underserved. 2013; 24(4 Suppl):38-47. PMC: 4209469. DOI: 10.1353/hpu.2014.0000. View

10.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

11.

Caro Y, Negron V, Palacios C . Association between vitamin D levels and blood pressure in a group of Puerto Ricans. P R Health Sci J. 2012; 31(3):123-9. PMC: 3700354. View

12.

Maki K, Fulgoni 3rd V, Keast D, Rains T, Park K, Rubin M . Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: National Health and Nutrition Examination Surveys 2003-2006. Metab Syndr Relat Disord. 2012; 10(5):363-72. DOI: 10.1089/met.2012.0020. View

13.

Awad A, Alappat L, Valerio M . Vitamin d and metabolic syndrome risk factors: evidence and mechanisms. Crit Rev Food Sci Nutr. 2011; 52(2):103-12. DOI: 10.1080/10408391003785458. View

14.

Minambres I, Sanchez-Hernandez J, Sanchez-Quesada J, Rodriguez J, DE Leiva A, Perez A . The association of hypovitaminosis d with the metabolic syndrome is independent of the degree of obesity. ISRN Endocrinol. 2012; 2012:691803. PMC: 3485873. DOI: 10.5402/2012/691803. View

15.

Forman J, Williams J, Fisher N . Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010; 55(5):1283-8. PMC: 3023301. DOI: 10.1161/HYPERTENSIONAHA.109.148619. View

16.

Perez C, Guzman M, Ortiz A, Estrella M, Valle Y, Perez N . Prevalence of the metabolic syndrome in San Juan, Puerto Rico. Ethn Dis. 2009; 18(4):434-41. PMC: 2717036. View

17.

Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17):2735-52. DOI: 10.1161/CIRCULATIONAHA.105.169404. View

18.

Pereira M, Jacobs Jr D, Van Horn L, Slattery M, Kartashov A, Ludwig D . Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002; 287(16):2081-9. DOI: 10.1001/jama.287.16.2081. View

19.

Brenner D, Arora P, Garcia-Bailo B, Wolever T, Morrison H, El-Sohemy A . Plasma vitamin D levels and risk of metabolic syndrome in Canadians. Clin Invest Med. 2011; 34(6):E377. DOI: 10.25011/cim.v34i6.15899. View

20.

Maki K, Rubin M, Wong L, McManus J, Jensen C, Marshall J . Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol. 2011; 3(4):289-96. DOI: 10.1016/j.jacl.2009.07.003. View